[1]
W. Wagner, “COMPLICATIONS OF CAR-T CELL THERAPY IN HEMATOLOGIC MALIGNANCIES — A CURRENT CLINICAL REVIEW OF TOXICITIES AND MANAGEMENT STRATEGIES”, IJITSS, vol. 4, no. 2(50), Jun. 2026, doi: 10.31435/ijitss.2(50).2026.5565.